Related content

Concordance of pharmacogenetic markers in germline and colorectal tumor DNA

By Marsh Sharon   Mallon Mary Ann   Goodfellow Paul   McLeod Howard L  

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 873-877

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity

By  

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 932-943

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic aspects in treatment of colorectal cancer – an update

By Stoehlmacher Jan   Goekkurt Eray   Lenz Heinz-Josef  

Pharmacogenomics, Vol. 4, Iss. 6, 2003-11 ,pp. : 767-777

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic determinants of anti-cancer drug activity and toxicity

By Danesi R.   De Braud F.   Fogli S.   Di Paolo A.   Del Tacca M.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 8, 2001-08 ,pp. : 420-426

Elsevier

Access to resources Recommend Favorite

Chemotherapy for Metastatic Colorectal Cancer

By Rosales Joseph   Leong Lucille A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 4, 2005-07 ,pp. : 525-529

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite